[Federal Register Volume 72, Number 59 (Wednesday, March 28, 2007)]
[Notices]
[Pages 14599-14600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-1511]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
Federal oversight of dual use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend should register online at http://www.biosecurityboard.gov/meetings.asp or by calling Capital Consulting Corporation (Contact: 
Karen Brooks at 301-468-6004, ext. 443. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should indicate these requirements 
upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: April 19, 2007.
    Open: 8 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Proposed 
strategies for oversight of life sciences research with dual use 
potential; (2) international dialogue on dual use research issues; 
(3) public comments; and (4) and other business of the Board.

[[Page 14600]]

    Place: The National Institutes of Health, 31 Center Drive, 
Building 31, C Wing, 6th Floor, Rooms 6-10, Bethesda, Maryland 
20892.
    Contact Person: Ronna Hill, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.

    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the webcast and pre-registration, will be available at http://ww.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by April 2, 207 and 
should be sent via e-mail to <a href="/cdn-cgi/l/email-protection#dfb1acbebdbd9fb0bbf1b1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="83edf0e2e1e1c3ece7adedeaebade4ecf5">[email protected]</span></a> with ``NSABB Public 
Comment'' as the subject line or by regular mail to 6705 Rockledge 
Drive, Suite 750, Bethesda, MD 20892, Attention Ronna Hill. The 
statement should include the name, address, telephone number and, 
when applicable, the business or professional affiliation of the 
interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID's 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: March 20, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1511 Filed 3-27-07; 8:45 am]
BILLING CODE 4140-07-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>